جستجوی استاد راهنمای دانشگاهی

Dr. Zhi-Ping Feng is a Bioinformatician at the John Curtin School of Medical Research (JCSMR), Australian National University (ANU). Her research focuses on integrating omics data with protein structure-function relationships to study interactions between macromolecules. She has expertise in analyzing genomic and transcriptomic data (e.g., RNA-Seq, ChIP-Seq) and protein structure determination via nuclear magnetic resonance (NMR) spectroscopy. Previously, she held a Senior Research Fellow position at the Walter and Eliza Hall Institute (WEHI) from 2009, working on quality control in omics research and genomic data analysis. Her postdoctoral work at WEHI (2002–2005) involved structural biology of malaria-related proteins, supported by an Australian Postdoctoral Fellowship. She holds a PhD in protein bioinformatics from China and a physics background from Peking University. Education: PhD in Protein Bioinformatics (China) Bachelor’s in Physics, Peking University Research Interests: Her work bridges computational biology and structural biology, with emphasis on: Intrinsically unstructured proteins (IUPs) and their applications in malaria proteomics Omics data integration for disease modeling (e.g., cancer, diabetes, neurodegeneration) Protein-protein interaction networks and structural bioinformatics Publications: Recent work spans cancer immunotherapy, miRNA regulation in retinal degeneration, and T cell biology, with contributions to understanding Wnt signaling in joint replacement complications and genetic fusions in pediatric brain tumors. Awards: Australian Postdoctoral Fellowship (2005) Grants/Teams: Currently affiliated with ANU Bioinformatics Consultancy, supporting translational medical research in immunology, cancer, and genomics. Labs/Teams: Collaborates with the JCSMR’s multidisciplinary teams focusing on biomedical informatics and translational research.

• Bioinformatics
• Genomics
• Proteomics
• +۳ مورد دیگر

Senani N.H. Rathnayake is a Research Fellow at the University of Technology Sydney (UTS), Faculty of Science. He completed his PhD at UTS (2019-2024) and held a Postdoctoral Fellowship at the University of Groningen (2023-2024). His primary research focuses on respiratory diseases, particularly the molecular mechanisms of smoking-induced lung damage, COPD, and asthma. Key areas include gene expression profiling, epigenetic changes, and cellular responses to cigarette smoke exposure. Research Interests: Transcriptomic and epigenetic alterations in lung diseases Smoking cessation effects on airway biology Genetic regulation of COPD biomarkers (e.g., sRAGE) Sex chromosome influences on respiratory disease susceptibility Awards & Fellowships: 2023 TSANZ Past Presidents Scholarship Award 2022-2023 European Respiratory Society Short-Term Fellowship Recent Research Trends: His articles emphasize smoking's impact on bronchial epithelial cells, including transcriptomic shifts, mucus barrier dynamics, and CRISPR-based gene-editing applications. Recent work explores Y-chromosome effects on COPD and asthma pathogenesis. Professional Engagement: Co-chair of the 2023 TSANZ Annual Scientific Conference Member of Australian Society for Medical Research, European Respiratory Society, and Thoracic Society of Australia and New Zealand

• Respiratory diseases
• Epigenetics
• Molecular Biology
• +۵ مورد دیگر

Dr. Sheng-Jian Ji is a Tenured Associate Professor at the School of Life Sciences, Department of Neuroscience at Southern University of Science and Technology (SUSTech) in Shenzhen, China. He also serves as the Academic Vice President of Shude Academy and was previously the first Deputy Director of Research and Graduate Affairs in the Department of Biology at SUSTech (2016-2018). As a leading neuroscientist specializing in RNA modification and neural development, Dr. Ji has established an internationally recognized research program. Dr. Ji's educational background includes: 2003-2007: Postdoctoral Fellow, Johns Hopkins University School of Medicine, Neurobiology 1998-2003: PhD in Biochemistry and Molecular Biology, Peking University School of Life Sciences 1994-1998: Bachelor's Degree in Biochemistry, Yantai University Department of Biochemistry Dr. Ji's research primarily focuses on developmental neurobiology, with particular emphasis on post-transcriptional regulation mechanisms including RNA modification and local translation of mRNA in axons. His laboratory is recognized as one of the leading international groups studying how mRNA modification (particularly m6A and m5C) regulates neural development and function. Through innovative approaches combining molecular biology, cell biology, and microfluidic technologies, his team has revealed important insights into axon growth, dendrite maintenance, cortical neurogenesis, and retinal development. His publication record shows a clear trajectory from fundamental mechanisms of RNA modification to applications in understanding neurological disorders and aging. Recent work has expanded into aging-related neural decline, cognitive functions, and potential therapeutic targets for neurological conditions. Dr. Ji has received numerous prestigious awards: 2020, 2016: SUSTech Excellent College Mentor 2020: SUSTech Biology Department Outstanding Service Award 2019: Guangdong Province Talent Youyue Card A 2017: Guangdong Provincial Professor of Neurobiology 2013: Jiangsu Distinguished Professor (Nanjing University) 2011: National Natural Science Award Second Prize (third contributor) As an educator, Dr. Ji teaches undergraduate Neurobiology and graduate Cellular and Molecular Neurobiology courses. He actively mentors students, with recent master's graduates including Yuan Jiaxin and Zhang Pingrui. His laboratory recruits postdoctoral fellows (with salaries of 335,000+ RMB annually), research assistants, and graduate students, providing comprehensive training in molecular techniques, neuronal cell culture, microfluidics, and omics approaches. Dr. Ji leads a vibrant research team that collaborates both within SUSTech and internationally. His work continues to advance understanding of RNA modification in neural development, function, and aging, with recent progress highlighted in June 2025.

• Developmental Neurobiology
• RNA Modification
• Post-transcriptional Regulation
• +۴ مورد دیگر

Dr. Premdass Ramdas is a Senior Lecturer at Monash University Malaysia, affiliated with the Jeffrey Cheah School of Medicine and Health Sciences. He joined in October 2023 with over 13 years of experience in medical biotechnology and health sciences, focusing on cancer research and bioactive natural compounds. PhD in Cancer Proteomics and Genomics, University of Malaya MSc in Medical Sciences (Cancer Genomics and Natural Products), International Medical University BSc with First-Class Honors His research focuses on the anticancer mechanisms of tocotrienols, utilizing proteomics, genomics, bioinformatics, and mouse models. He explores epigenetics, nutrigenomics, RNA/microRNA analysis, exosome biology, and AI-driven big data in cancer. His work contributes to UN Sustainable Development Goals in health and well-being. Recent publications show a strong trend in systematic reviews and mechanistic studies on vitamin E analogues in cancer, particularly colorectal and breast cancers. His research integrates molecular biology with computational approaches, including molecular docking and data mining. First-class honors for BSc Malaysian Palm Oil Board Scholarship for MSc MyBrain15 Scholarship for PhD Dr. Ramdas has secured research grants such as FRGS and actively supervises research projects. He is currently accepting PhD students and has co-supervised non-HDR reviews, indicating active mentorship. He has no known labs or teams explicitly mentioned, but collaborates extensively, particularly with Prof. Radhakrishnan A.K.

• Cancer Cell Biology
• Quantitative Proteomics
• Genomics
• +۱۲ مورد دیگر

Pilar Blancafort is an Associate Professor at The University of Western Australia (UWA), holding positions in the School of Human Sciences and UWA Medical School. She is affiliated with the UWA Centre for Medical Research and collaborates with the Harry Perkins Institute of Medical Research. Her research focuses on epigenetic manipulation in cancer models, particularly breast and ovarian cancers, leveraging CRISPR/Cas9 and genome engineering technologies to develop precision medicine tools. She has co-led projects such as the Lionheart FX Automated High-Content Microscope initiative and actively investigates therapeutic reprogramming of cellular signaling pathways to improve cancer treatment outcomes. Blancafort’s research expertise includes genome engineering, cancer epigenetics, and women’s cancers. She collaborates internationally and has contributed to over 70 publications, 14 datasets, and 43 grants. Her work aligns with UN Sustainable Development Goals, emphasizing global health and innovation in medical research. Key areas of exploration involve reactivating tumor suppressors, silencing oncogenic drivers, and enhancing immune responses through CRISPR-based systems. Her studies on the PI3K-AKT-mTOR pathway and novel oncogenes further underscore her commitment to advancing targeted therapies. Blancafort has supervised 11 students and leads multiple grants, including projects on metastatic breast cancer therapies and ovarian cancer reprogramming. Her lab at the UWA Centre for Medical Research explores translational strategies for epigenome editing in cancer, with a focus on clinical applicability. Recent work highlights lipid nanoparticle delivery systems for CRISPR/dCas9 and synthetic epigenetic approaches to reverse mesenchymal-epithelial transitions in breast cancer.

• Cancer Biology
• Epigenetics
• Genome Engineering
• +۷ مورد دیگر

Eduardo Eyras is a Professor at the Australian National University (ANU) and EMBL Australia Group Leader, leading research in computational RNA biology and cancer genomics. He directs the Centre for Computational Biomedical Sciences and is part of the Shine-Dalgarno Centre for RNA Innovation. His work focuses on transcriptome and epitranscriptome analysis using long-read sequencing, machine learning, and computational methods to study cancer mechanisms. Eyras holds a PhD in Mathematics from the University of Groningen (1999) and previously led research at the Sanger Institute and Pompeu Fabra University. Affiliations: Director, Centre for Computational Biomedical Sciences Researcher, Shine-Dalgarno Centre for RNA Innovation Member, Division of Genome Sciences and Cancer Leader, The Eyras Group - Computational RNA Biology Research Interests: Development of algorithms for long-read sequencing Machine learning applications in RNA biology Epitranscriptomic modifications and cancer Therapeutic mRNA platform steering Key Projects: Novel algorithms for transcriptome variation analysis Predictive models of RNA modifications in disease Ribosomal DNA variation analysis Advisees & Grants: Supervises PhD students (e.g., Favour Oyelami, Stefan Prodic) and leads ARC-funded projects on mRNA diagnostics and epitranscriptomic therapies. Collaborates with global teams on forensic genomics, cancer drug resistance, and AI-driven translational research. Labs/Teams: Leads the Eyras Group, collaborating with the Hannan Group (Cancer Therapeutics) and Shirokikh Group (Protein Biosynthesis).

• RNA Biology
• Cancer Research
• Long-read Sequencing Technologies
• +۴ مورد دیگر

Robert Sharwood is a Senior Lecturer in Translational Photosynthesis and Vice-Chancellor's Senior Research Fellow at Western Sydney University. His research focuses on improving crop resilience to climate change through enhancing photosynthetic efficiency in plants like cotton, wheat, and Eucalyptus. He leads projects on Rubisco biochemistry, C3/C4 photosynthesis pathways, and synthetic biology applications for crop adaptation. His expertise spans chloroplast RNA biology, plant physiology, and biotechnology. Notable grants include the Australian Research Council Discovery Program (2023–2024) and collaborations with the Cotton Research and Development Corporation. Awards include the Excellence in Teaching Award (2024) and recognition as a Top Botany Research Leader in Australia (2018). Key research themes include developing heat/drought-resistant crops, optimizing CO2 assimilation, and advancing protected cropping systems. His work bridges fundamental plant science with applied agricultural solutions, aiming to future-proof global food production.

• Translational Photosynthesis
• Climate-Adapted Crop Improvement
• Plant Physiology
• +۴ مورد دیگر

Professor Amanda Able is a Professor in Plant Science at the University of Adelaide, affiliated with the School of Agriculture, Food and Wine within the Faculty of Sciences, Engineering and Technology. She leads research on plant-pathogen interactions, postharvest physiology, and climate stress resilience in crops. With over $9M in competitive grants since 2001, her work focuses on durum wheat stress responses, miRNA regulation, and transgenerational epigenetic effects. She has supervised 18 PhD and 1 MSc graduates since 2002. Awards include the 2006 Tall Poppy of the Year and 2015 USQ Research Alumnus of the Year. Teaching contributions include Deputy Dean (Learning & Teaching) roles (2019–2022), ASPS Teaching Award (2009), and leadership in national education initiatives like the Agriculture Learning and Teaching Academic Standards project. Her Get into Genes program for secondary students won awards for promoting plant science education. Research spans plant disease mechanisms, capsicum ripening, and inquiry-based learning scaffolding. Her 15 most recent articles (2020–2025) emphasize transgenerational stress memory in crops, microRNA networks, and career readiness in science graduates. Collaborations include the Molecular Plant Breeding CRC and ACDA Learning and Teaching Academy. Labs focus on integrative omics approaches to stress biology and agricultural innovation.

• Plant-Pathogen Interactions
• Postharvest Physiology
• Plant Disease Management
• +۴ مورد دیگر

Associate Professor Robert Nordon is a faculty member at UNSW Sydney's Graduate School of Biomedical Engineering. He holds an MB BS, BMedSci, and PhD, with research focusing on advanced manufacturing and medical technologies. Since 2016, he has secured over $5M in research grants for projects in point-of-care diagnostics, cell/gene therapy manufacturing, and stem cell science. Research interests span three primary domains: Developing microfluidic single-use disposables for scalable clinical cell production Modeling cardiovascular development using stem cell-based microfluidic systems Creating computational tools for single-cell analysis and lineage tracking His publications (2017-2024) demonstrate strong emphasis on microfluidic device engineering, stem cell dynamics, and biomaterials development. Recurring themes include hematopoietic stem cell expansion, cardiac cell behavior, and peptide-based biomaterials. Significant grants include: ARC Linkage Grant LP160100570: Scaling microfluidics for cell manufacture (2016-2019) ARC Linkage Grant LP160100573: 3D microstructures for medical devices (2016-2019) ARC Linkage Grant LP190100029: Electrophoretic cell sorters (2020-2023) CRC-P: Microbioreactor for affordable cell/gene therapy (2021-2023) Current research trainees include Farzaneh Ziaee and Eric Du.

• Biomedical Engineering
• Advanced Manufacturing
• Medical Technologies
• +۵ مورد دیگر

Professor Marcel Dinger is a prominent academic and researcher currently serving as Professor and Head of School for Biotechnology and Biomolecular Sciences at UNSW Sydney. With over 20 years of experience in genomics, he has established himself as a leading figure in both academic and entrepreneurial spheres within the field. He has published 153 papers with over 24,000 citations and maintains an h-index of 61 on Google Scholar. His leadership extends beyond academia as he serves as President of the Australasian Genomics Technologies Association (AGTA) and holds director positions at Pryzm Health and the National Centre for Indigenous Genomics (NCIG). Professor Dinger's research laboratory focuses on establishing new links between phenotype and genotype, particularly examining rare and complex diseases in relation to underexplored regions of the genome including pseudogenes, repetitive elements, non-canonical DNA structures, and noncoding RNAs. His work harnesses population-scale genomic datasets and sophisticated data science methods to bring an objective perspective to understanding how the genome stores information and how it is transacted in biology. His research interests span genomics, non-coding RNA biology, clinical applications of genomic medicine, and the development of computational approaches for analyzing complex genomic data. Analysis of Professor Dinger's recent publications reveals a strong emphasis on non-coding RNA research, particularly long noncoding RNAs and their roles in disease mechanisms. His work spans cancer genomics, neurological disorders, and fundamental genomic mechanisms including DNA secondary structures like i-motifs and G-quadruplexes. His research combines experimental approaches with advanced bioinformatics to address fundamental questions in genomic medicine and has significant translational implications for disease diagnosis and treatment. Highly Cited Researcher in Cross-Field category (2019, 2020, 2021) Fellow of the Faculty of Science (Research), Royal Society of Pathologists of Australasia (2016) NHMRC Career Development Award (2010) Queensland Government Smart Futures Fellowship (2009) Foundation of Research, Science and Technology New Zealand Postdoctoral Fellowship (2005) Professor Dinger has been instrumental in establishing and leading several significant research initiatives including Genome.One, one of the first companies globally to provide clinical whole genome sequencing services, and the Kinghorn Centre for Clinical Genomics at the Garvan Institute of Medical Research. His entrepreneurial experience includes founding four biotechnology and IT startups. He serves on multiple governance boards including the National Centre for Indigenous Genomics, focusing on using genomics to improve health outcomes for Australia's First Peoples. His laboratory at UNSW continues to advance our understanding of genomic regulation and its implications for human health and disease.

• Genomics
• Non-coding RNA research
• Phenotype-genotype relationships
• +۷ مورد دیگر

Associate Professor Jean (Jiayu) Wen holds positions at The Australian National University (ANU), including Group Leader of The Wen Group, ARC Future Fellow, and Deputy Director of The Shine-Dalgarno Centre for RNA Innovation. She specializes in computational and molecular biology, focusing on RNA regulation, gene expression, and cancer genomics. Her affiliations include ANU’s Division of Genome Sciences and Cancer, and the Centre for Computational Biomedical Sciences. Education: BEng in Electronic Engineering (Beijing), MSc in Computer Science (Lakehead University), PhD in Computational Biology (ANU). Postdoctoral training at Copenhagen University and Memorial Sloan-Kettering Cancer Center. Research interests span RNA structures, microRNA biogenesis, transcriptome dynamics, and epigenetic regulation. Her work addresses intragenomic conflicts, cancer mechanisms, and neural development. Notable projects include RNA-based machine learning models for RNA-RNA interactions and immune cell differentiation studies. Publications highlight contributions to RNA interference pathways, tumor development, and Drosophila genetics. Awards include the ARC Future Fellowship. She leads interdisciplinary teams advancing computational and experimental approaches in genomics and systems biology.

• RNA Biology
• Computational Biology
• MicroRNA Regulation
• +۵ مورد دیگر

Associate Professor Timothy Bredy is a leading figure in cognitive neuroepigenetics at the Queensland Brain Institute (QBI) , focusing on how epigenetic modifications and RNA dynamics regulate fear-related memory and psychiatric disorders like PTSD. His research explores the interplay between environmental experiences and genomic activity, particularly through non-coding RNA and DNA methylation. University: University of Queensland School: Faculty of Health, Medicine and Behavioural Sciences Role: Professorial Research Fellow and Group Leader Research Interests span epigenetic mechanisms in memory formation, RNA modifications in synaptic plasticity, and therapeutic applications for anxiety disorders. He pioneered discoveries linking dynamic DNA structures (e.g., G-quadruplexes) and RNA methylation to memory stability. Recent Work includes studies on RNA-based therapeutics, stress-induced epigenetic inheritance, and synaptic long noncoding RNA activity. His scientific awards encompass NHMRC and ARC grants for neuroepigenetics research. Key Collaborators: Paul Marshall, Esmi Zajaczkowski Labs: Bredy Laboratory at QBI

• Epigenetics
• Fear-Related Memory
• RNA Biology
• +۶ مورد دیگر

Dr. Laura Leighton is a Postdoctoral Research Fellow in the mRNA Sciences group at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. Her research focuses on RNA biology, particularly the functional characterization of RNA molecules and their roles in cancer therapy and neurological processes. She leads the development of mRNA-based therapeutics for liver cancer, leveraging lipid nanoparticle (LNP) delivery systems to target intracellular cancer proteins. Dr. Leighton holds a PhD from the Queensland Brain Institute (2021), where her work, supported by the Westpac Future Leaders Scholarship, explored small noncoding RNAs in fear-related learning and memory. She completed her postdoctoral training under Dr. Seth Cheetham at AIBN in 2023. Her educational background includes a Bachelor of Science and Bachelor of Science (Honours) from The University of Queensland. Her research interests integrate molecular biology, neuroscience, and translational medicine, with a focus on RNA modifications (e.g., m6A), long noncoding RNAs, and the epigenetic regulation of memory processes. Key themes in her work include fear extinction mechanisms, synaptic plasticity, and the application of mRNA therapeutics in cancer treatment. Dr. Leighton’s articles consistently explore RNA-driven mechanisms in memory and disease. Recent work highlights the role of DNA G-quadruplex structures in memory regulation, the interplay between stress hormones and sperm RNA dysregulation, and the synthesis of novel long noncoding RNAs (e.g., ADRAM) that drive fear extinction. Her findings bridge basic neuroscience and clinical applications, emphasizing RNA’s dynamic role in health and disease. Awards: Westpac Future Leaders Scholarship (2017) Grants: TdC Mid Career Grant (Targeting liver cancer with mRNA therapies), Prader Willi Syndrome Research Grant (2022–2024) She is actively involved in supervising research students and contributes to the development of advanced drug delivery systems targeting liver cancers. Her lab is part of AIBN’s mRNA Sciences team, collaborating on projects that translate RNA-based discoveries into clinical solutions.

• RNA Biology
• mRNA Therapeutics
• Gene Therapy
• +۳ مورد دیگر

Professor Shan Rajendra is a distinguished researcher in the Faculty of Medicine at the University of New South Wales, specializing in gastroenterology with a particular focus on the relationship between human papillomavirus (HPV) and esophageal pathologies. His work is conducted through NSW Health in Liverpool, NSW, where he leads research investigating the infectious causes of gastrointestinal cancer with special emphasis on Barrett's oesophagus. Professor Rajendra's research interests center on oesophageal cancer , human papillomavirus , Barrett's oesophagus , and the Barrett's metaplasia-dysplasia-adenocarcinoma sequence . His laboratory employs histopathology and molecular biology techniques to investigate the mechanisms by which high-risk HPV contributes to esophageal carcinogenesis. A significant contribution to the field was his world-first demonstration of the strong association between transcriptionally active high-risk HPV and both Barrett's dysplasia and oesophageal adenocarcinoma, with increasing viral load correlating with greater disease severity. His publication record includes 53 journal articles, 10 conference papers, and 1 book chapter, reflecting substantial contributions to understanding HPV's role in esophageal cancer development. The research has important implications for potential vaccination strategies against a subset of esophageal cancers. Professor Rajendra maintains active clinical and research connections through his work at NSW Health, with his findings contributing to both basic science understanding and potential clinical applications in cancer prevention and early detection.

• Gastroenterology
• Hepatology
• Oesophageal cancer
• +۳ مورد دیگر

Dr. Pouya Faridi is a Senior Research Fellow at Monash University's School of Clinical Sciences and heads the Translational Antigen Discovery Laboratory. He holds a pharmacy doctorate and PhD from Shiraz University of Medical Sciences, Iran, followed by postdoctoral research at ETH Zurich and Monash University. His research focuses on developing mass-spectrometry and proteomics technologies for identifying cancer immunotherapy targets, with clinical applications in cancer vaccines. He co-directs the Monash Clinical Proteomics Facility and leads projects funded by NHMRC, Cancer Australia, and the Victorian Cancer Agency. **Education**: PharmD, Shiraz University of Medical Sciences, Iran PhD, Shiraz University of Medical Sciences, Iran **Research Interests**: Biomarker discovery via mass spectrometry Immunopeptidome analysis for precision oncology Development of novel cancer vaccines Proteomics-based theranostics **Awards & Grants**: Victorian Cancer Agency mid-career fellowship (2021) Australian Melanoma Research Foundation Early Career Award (2021) Lead investigator on NHMRC grants targeting tumor antigens Supported by Isabella & Marcus Foundation for pediatric brain tumor research **Labs & Teams**: Translational Antigen Discovery Laboratory (Monash) Co-director of Monash Clinical Proteomics Facility Collaborations with Hudson Institute of Medical Research

• Proteomics
• Cancer Immunotherapy
• Mass Spectrometry
• +۳ مورد دیگر